Novartis AG
Patents, Design & Utilities

Last updated:

List of all Novartis AG patents 1,223 in total

Status Patent
Application
Utility: COMBINATION OF PI3K INHIBITOR AND C-MET INHIBITOR External link
Filling date: 23 Sep 2025 Issue date: 8 Sep 2022
Application
Utility: AZA-QUINOLINE COMPOUNDS AND USES THEREOF External link
Filling date: 23 Sep 2025 Issue date: 8 Sep 2022
Application
Utility: Pharmaceutical Combinations External link
Filling date: 23 Sep 2025 Issue date: 8 Sep 2022
Grant
Utility: Solid forms comprising an oxime ether compound and a coformer, compositions and methods of use thereof External link
Filling date: 23 Sep 2025 Issue date: 6 Sep 2022
Grant
Utility: Process and intermediates External link
Filling date: 23 Sep 2025 Issue date: 6 Sep 2022
Grant
Utility: Polyomavirus neutralizing antibodies External link
Filling date: 23 Sep 2025 Issue date: 6 Sep 2022
Grant
Utility: Methods for treating disease using inhibitors of bone morphogenetic protein 6 (BMP6) External link
Filling date: 23 Sep 2025 Issue date: 6 Sep 2022
Grant
Utility: Automated viscous fluid control in vitreoretinal surgery External link
Filling date: 23 Sep 2025 Issue date: 6 Sep 2022
Application
Utility: ORGANIC COMPOUNDS External link
Filling date: 23 Sep 2025 Issue date: 1 Sep 2022
Application
Utility: SURFACTANT SYSTEMS FOR CRYSTALLIZATION OF ORGANIC COMPOUNDS External link
Filling date: 23 Sep 2025 Issue date: 1 Sep 2022
Application
Utility: PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA) LIGANDS AND USES THEREOF External link
Filling date: 23 Sep 2025 Issue date: 1 Sep 2022
Grant
Utility: 1,2,4-oxadiazole derivatives as liver X receptor agonists External link
Filling date: 23 Sep 2025 Issue date: 30 Aug 2022
Grant
Utility: Substituted bisphenyl butanoic ester derivatives as NEP inhibitors External link
Filling date: 23 Sep 2025 Issue date: 30 Aug 2022
Grant
Utility: Computer processes behind an enhanced version of aqua External link
Filling date: 23 Sep 2025 Issue date: 30 Aug 2022
Grant
Utility: Lipoic acid choline ester compositions and methods of use External link
Filling date: 23 Sep 2025 Issue date: 30 Aug 2022
Application
Utility: USES OF MYOSTATIN ANTAGONISTS, COMBINATIONS CONTAINING THEM AND USES THEREOF External link
Filling date: 23 Sep 2025 Issue date: 25 Aug 2022
Application
Utility: COMBINATION TREATMENT OF LIVER DISEASES USING FXR AGONISTS External link
Filling date: 23 Sep 2025 Issue date: 25 Aug 2022
Application
Utility: NEW CRYSTALLINE FORMS OF N-(3-(2-(2-HYDROXYETHOXY)-6-MORPHOLINOPYRIDIN-4-YL)-4-METHVLPHENYL)-2 (TRIFLUOROMETHYL)ISONICOTINAMIDE AS RAF INHIBITORS FOR THE TREATMENT OF CANCER External link
Filling date: 23 Sep 2025 Issue date: 25 Aug 2022
Application
Utility: NLRP MODULATORS External link
Filling date: 23 Sep 2025 Issue date: 25 Aug 2022
Grant
Utility: Piperidinyl-methyl-purineamines as NSD2 inhibitors and anti-cancer agents External link
Filling date: 23 Sep 2025 Issue date: 23 Aug 2022
Grant
Utility: Lipids and lipid compositions for the delivery of active agents External link
Filling date: 23 Sep 2025 Issue date: 23 Aug 2022
Grant
Utility: Intermittent dosing of MDM2 inhibitor External link
Filling date: 23 Sep 2025 Issue date: 23 Aug 2022
Application
Utility: MEDICAL CONTAINER WITH NFC ANTENNA External link
Filling date: 23 Sep 2025 Issue date: 18 Aug 2022
Application
Utility: TREATMENT COMPRISING SGLT INHIBITORS External link
Filling date: 23 Sep 2025 Issue date: 18 Aug 2022
Application
Utility: METHODS FOR TREATING MEIBOMIAN GLAND DYSFUNCTION WITH LIVER X RECEPTOR AGONISTS External link
Filling date: 23 Sep 2025 Issue date: 18 Aug 2022
Grant
Utility: Systems and methods for intra-ocular lens advancement External link
Filling date: 23 Sep 2025 Issue date: 16 Aug 2022
Grant
Utility: Protein kinase C inhibitors for treatment of uveal melanoma External link
Filling date: 23 Sep 2025 Issue date: 16 Aug 2022
Grant
Utility: Chemical process for manufacturing monobactam antibiotic and intermediates thereof External link
Filling date: 23 Sep 2025 Issue date: 16 Aug 2022
Grant
Utility: Mesothelin chimeric antigen receptor (CAR) and antibody against PD-L1 inhibitor for combined use in anticancer therapy External link
Filling date: 23 Sep 2025 Issue date: 16 Aug 2022
Application
Utility: METHODS OF TREATING OR AMELIORATING METABOLIC DISORDERS USING GROWTH DIFFERENTIATION FACTOR 15 (GDF-15) External link
Filling date: 23 Sep 2025 Issue date: 11 Aug 2022
Application
Utility: NLRP3 INFLAMMASOME INHIBITORS External link
Filling date: 23 Sep 2025 Issue date: 11 Aug 2022
Application
Utility: METHODS FOR REDUCING THE OXIDATION LEVEL OF CYSTEINE RESIDUES IN A SECRETED RECOMBINANTLY-EXPRESSED PROTEIN DURING CELL CULTURE External link
Filling date: 23 Sep 2025 Issue date: 11 Aug 2022
Application
Utility: COMPOSITIONS AND METHODS FOR SELECTIVE PROTEIN DEGRADATION External link
Filling date: 23 Sep 2025 Issue date: 11 Aug 2022
Grant
Utility: Crystalline forms of N-[4-(Chlorodifluoromethoxy)phenyl]-6-[(3R)-3-hydroxypyrrolidin-1-yl]-5-(- 1H-pyrazol-5-yl)pyridine-3-carboxamide External link
Filling date: 23 Sep 2025 Issue date: 9 Aug 2022
Grant
Utility: Combinations of MDM2 inhibitors with inhibitors of ERK for treating cancers External link
Filling date: 23 Sep 2025 Issue date: 9 Aug 2022
Grant
Utility: Dosing schedule of a Wnt inhibitor and an anti-PD-1 antibody molecule in combination External link
Filling date: 23 Sep 2025 Issue date: 9 Aug 2022
Grant
Utility: Reclosable folding box with a tamper-evident closure, and folding box blank for producing same External link
Filling date: 23 Sep 2025 Issue date: 9 Aug 2022
Application
Utility: PHARMACEUTICAL COMBINATION COMPRISING AN ALK INHIBITOR AND A SHP2 INHIBITOR External link
Filling date: 23 Sep 2025 Issue date: 4 Aug 2022
Application
Utility: CELL BAG ROTATOR External link
Filling date: 23 Sep 2025 Issue date: 4 Aug 2022
Application
Utility: RAPAMYCIN DERIVATIVES External link
Filling date: 23 Sep 2025 Issue date: 4 Aug 2022
Application
Utility: SYSTEMS AND METHODS FOR USER VERIFICATION BASED ON ACTIGRAPHY DATA External link
Filling date: 23 Sep 2025 Issue date: 4 Aug 2022
Grant
Utility: 1-Pyridazin-/triazin-3-yl-piper(-azine)/idine/pyrolidine derivatives and compositions thereof for inhibiting the activity of SHP2 External link
Filling date: 23 Sep 2025 Issue date: 2 Aug 2022
Grant
Utility: Inhaler adapted to read information stored in data storage means of a container External link
Filling date: 23 Sep 2025 Issue date: 2 Aug 2022
Grant
Design: Container for pharmaceuticals External link
Filling date: 23 Sep 2025 Issue date: 2 Aug 2022
Grant
Design: Container for pharmaceuticals External link
Filling date: 23 Sep 2025 Issue date: 2 Aug 2022
Application
Utility: Pharmaceutical Composition External link
Filling date: 23 Sep 2025 Issue date: 28 Jul 2022
Application
Utility: INTERMITTENT DOSING OF MDM2 INHIBITOR External link
Filling date: 23 Sep 2025 Issue date: 28 Jul 2022
Application
Utility: COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH NLRP ACTIVITY External link
Filling date: 23 Sep 2025 Issue date: 21 Jul 2022
Grant
Utility: Sustained delivery of angiopoetin-like 3 polypeptides External link
Filling date: 23 Sep 2025 Issue date: 19 Jul 2022
Application
Utility: Constitutive Yeast LLP Promotor-Based Expression Systems External link
Filling date: 23 Sep 2025 Issue date: 14 Jul 2022

Showing 1 to 50 of 1223 patents.